Ignite Creation Date:
2024-05-05 @ 4:47 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00310479
Status:
COMPLETED
Last Update Posted:
2016-02-25
First Post:
2006-04-03
Brief Title:
Clinico-pathologic Correlative Study of 3T Magnetic Resonance Spectroscopy in the Localization of Prostate Cancer
Sponsor:
AHS Cancer Control Alberta
Organization:
AHS Cancer Control Alberta
Study Overview
Official Title:
Clinico-pathologic Correlative Study of 3T Magnetic Resonance Spectroscopy in the Localization of Prostate Cancer
Status:
COMPLETED
Status Verified Date:
2012-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
We seek to develop an advanced imaging approach to identifying and localizing prostate cancer We believe that high field MRI magnetic resonance imaging has the potential to do this and we will endeavor to prove this by having patients with prostate cancer pre-operatively undergo a technique called magnetic resonance spectroscopy After surgery the microscopic locations of cancer will be compared with the pre-operative images to assess how well the imaging technique succeeds
Detailed Description:
The proposed research is enormously relevant to the clinical understanding of early prostate cancer We propose to test to see whether characteristic patterns of invivo 3T MRSI associated metabolites can be identified in correlation with clinically active tumor reserved on histopathologic analysis of resected specimens We also plan to demonstrate that 3T MR spectra of prostate cancer will allow for more detailed metabolic assessment with higher sensitivity specificity and accuracy and publish results established from MR spectra using 15T MR units Functional imaging eg molecular imaging such as this is felt to be the clinical wave of the future for cancer imaging and if successful will assume a very major role in the detection assessment treatment planning and delivery of drugs radiation heat and novel therapeutics in the fight against prostate cancer
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None